Johnson & Johnson as of Sept. 30, 2026
Portfolio Holdings for Johnson & Johnson
Johnson & Johnson holds 15 positions in its portfolio as reported in the September 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Protagonist Therapeutics (PTGX) | 45.3 | $345M | 2.4M | 140.89 | |
| Nanobiotix Sponsored Ads (NBTX) | 23.0 | $175M | 5.6M | 31.16 | |
| Meiragtx Holdings (MGTX) | 9.6 | $73M | 6.6M | 11.00 | |
| Rapport Therapeutics (RAPP) | 7.9 | $60M | 1.8M | 33.60 | |
| Contineum Therapeutics Cl A (CTNM) | 3.5 | $27M | 2.0M | 13.42 | |
| Cerebras Systems Com Cl A (CBRS) | 3.0 | $23M | 129k | 177.65 | |
| Xencor (XNCR) | 2.5 | $19M | 748k | 24.95 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.1 | $16M | 815k | 19.89 | |
| Fate Therapeutics (FATE) | 1.1 | $8.0M | 3.4M | 2.37 | |
| CVRX (CVRX) | 0.9 | $7.0M | 4.0M | 1.75 | |
| Procept Biorobotics Corp (PRCT) | 0.9 | $6.5M | 358k | 18.22 | |
| Neumora Therapeutics (NMRA) | 0.1 | $1.1M | 1.8M | 0.60 | |
| Vor Biopharma Com New (VOR) | 0.1 | $1.0M | 54k | 19.08 | |
| D Fluidigm Corp Del (LAB) | 0.0 | $231k | 312k | 0.74 | |
| Adicet Bio Com New (ACET) | 0.0 | $163k | 23k | 7.14 |
